Reducing Opioid Prescribing after Cesarean Delivery by Utilizing a Tailored Opioid Prescribing Algorithm

Christine P. McKenzie; Lacey E. Straube; Carolyn M. Webster; Matthew E. Nielsen; Alison M. Stuebe

doi:10.1055/a-2184-0423

American Journal of Perinatology, Inhaltsverzeichnis

Am J Perinatol 2024; 41(S 01): e2934-e2940
DOI: 10.1055/a-2184-0423

Original Article

Reducing Opioid Prescribing after Cesarean Delivery by Utilizing a Tailored Opioid Prescribing Algorithm

Autor*innen

Christine P. McKenzie

¹Division of Obstetric Anesthesia, Department of Anesthesiology, University of North Carolina, Chapel Hill, North Carolina
Lacey E. Straube

¹Division of Obstetric Anesthesia, Department of Anesthesiology, University of North Carolina, Chapel Hill, North Carolina
Carolyn M. Webster

²Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina
Matthew E. Nielsen

³Department of Urology, University of North Carolina, Chapel Hill, North Carolina
Alison M. Stuebe

²Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina

⁴Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Abstract

Objective There are increasing efforts among health care systems to promote safe opioid prescribing; however, best practice for minimizing overprescription is not established. Our study aimed to evaluate the effect of a tailored opioid prescribing algorithm on opioid prescription quantities.

Study Design A tailored opioid prescribing algorithm was developed to provide a recommended prescription quantity based on inpatient opioid use. A retrospective analysis of opioid prescribing 3 months before and after implementation was performed. Our primary outcome was the number of oxycodone 5-mg tablets prescribed. Subgroup analysis by oxycodone consumption in the 24 hour prior to discharge was performed. Patient satisfaction and unused opioid tablets were assessed by text message survey 2 weeks' postpartum.

Results We included 627 (n = 313 preimplementation; n = 314 postimplementation) patients who underwent cesarean delivery. Clinical characteristics were similar between groups. The median number of oxycodone 5-mg tablets prescribed in the baseline group was 20 (interquartile range [IQR]: 20–30), compared with 5 (IQR: 0–10) in the tailored prescribing group (p < 0.0001). For patients with no opioid use in the 24 hours prior to discharge, the median number of tablets prescribed decreased from 20 (IQR: 10–20) to 0 (IQR: 0–5) following the intervention (p < 0.0001). The proportion of patients discharged without an opioid prescription increased from 7% (23/313) in the baseline group to 35% (111/314) in the tailored prescribing group (odds ratio: 6.9, 95% confidence interval [4.3, 11.1]).

Conclusion Tailored opioid prescribing reduced the number of opioid tablets prescribed and increased the proportion of patients who were discharged without an opioid prescription.

Key Points

Opioid prescribing should be tailored by inpatient use.
Tailored prescribing reduced opioid prescription amounts.
Many patients do not require an opioid prescription.

Keywords

cesarean delivery - obstetrics - opioid - opioid consumption - opioid prescription - opioid stewardship - quality improvement - cesarean analgesia

Volltext

Referenzen

References
1 Bateman BT, Cole NM, Maeda A. et al. Patterns of opioid prescription and use after cesarean delivery. Obstet Gynecol 2017; 130 (01) 29-35
2 Osmundson SS, Schornack LA, Grasch JL, Zuckerwise LC, Young JL, Richardson MG. Postdischarge opioid use after cesarean delivery. Obstet Gynecol 2017; 130 (01) 36-41
3 Osmundson SS, Raymond BL, Kook BT. et al. Individualized compared with standard postdischarge oxycodone prescribing after cesarean birth: a randomized controlled trial. Obstet Gynecol 2018; 132 (03) 624-630
4 Hill MV, Stucke RS, Billmeier SE, Kelly JL, Barth Jr RJ. Guideline for discharge opioid prescriptions after inpatient general surgical procedures. J Am Coll Surg 2018; 226 (06) 996-1003
5 Chen EY, Marcantonio A, Tornetta III P. Correlation between 24-hour predischarge opioid use and amount of opioids prescribed at hospital discharge. JAMA Surg 2018; 153 (02) e174859
6 Badreldin N, Grobman WA, Chang KT, Yee LM. Opioid prescribing patterns among postpartum women. Am J Obstet Gynecol 2018; 219 (01) 103.e1-103.e8
7 Madsen AM, Stark LM, Has P, Emerson JB, Schulkin J, Matteson KA. Opioid knowledge and prescribing practices among obstetrician-gynecologists. Obstet Gynecol 2018; 131 (01) 150-157
8 Prabhu M, McQuaid-Hanson E, Hopp S. et al. A shared decision-making intervention to guide opioid prescribing after cesarean delivery. Obstet Gynecol 2017; 130 (01) 42-46
9 Prabhu M, Dubois H, James K. et al. Implementation of a quality improvement initiative to decrease opioid prescribing after cesarean delivery. Obstet Gynecol 2018; 132 (03) 631-636
10 Komatsu R, Carvalho B, Flood PD. Recovery after nulliparous birth: a detailed analysis of pain analgesia and recovery of function. Anesthesiology 2017; 127 (04) 684-694
11 Valentine AR, Carvalho B, Lazo TA, Riley ET. Scheduled acetaminophen with as-needed opioids compared to as-needed acetaminophen plus opioids for post-cesarean pain management. Int J Obstet Anesth 2015; 24 (03) 210-216
12 Poljak D, Chappelle J. The effect of a scheduled regimen of acetaminophen and ibuprofen on opioid use following cesarean delivery. J Perinat Med 2020; 48 (02) 153-156
13 ACOG Committee Opinion No. ACOG committee opinion no. 742: postpartum pain management. Obstet Gynecol 2018; 132 (01) e35-e43